

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | embryonic viscerocranium morphogenesis (GO:0048703) | 7.93098230 |
| 2 | peptide cross-linking (GO:0018149) | 6.78140927 |
| 3 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.15288832 |
| 4 | desmosome organization (GO:0002934) | 5.88562104 |
| 5 | hemidesmosome assembly (GO:0031581) | 5.41562765 |
| 6 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.15683799 |
| 7 | negative regulation of dendrite development (GO:2000171) | 4.85188750 |
| 8 | segment specification (GO:0007379) | 4.64350799 |
| 9 | reactive oxygen species biosynthetic process (GO:1903409) | 4.55286759 |
| 10 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.47007964 |
| 11 | thyroid hormone metabolic process (GO:0042403) | 4.30736808 |
| 12 | positive regulation of vesicle fusion (GO:0031340) | 4.06579776 |
| 13 | middle ear morphogenesis (GO:0042474) | 4.03914239 |
| 14 | establishment of mitochondrion localization (GO:0051654) | 4.03325414 |
| 15 | osteoblast development (GO:0002076) | 4.02283114 |
| 16 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.00390108 |
| 17 | mitochondrion transport along microtubule (GO:0047497) | 4.00390108 |
| 18 | motor neuron axon guidance (GO:0008045) | 4.00194014 |
| 19 | forebrain morphogenesis (GO:0048853) | 3.95004662 |
| 20 | endothelium development (GO:0003158) | 3.90060301 |
| 21 | cardiac epithelial to mesenchymal transition (GO:0060317) | 3.72671259 |
| 22 | keratinization (GO:0031424) | 3.60506555 |
| 23 | regulation of glomerular filtration (GO:0003093) | 3.56923264 |
| 24 | positive regulation of respiratory burst (GO:0060267) | 3.55679144 |
| 25 | superoxide anion generation (GO:0042554) | 3.53116867 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50127281 |
| 27 | cartilage morphogenesis (GO:0060536) | 3.46300312 |
| 28 | mammary gland epithelial cell differentiation (GO:0060644) | 3.44779419 |
| 29 | endoplasmic reticulum organization (GO:0007029) | 3.42521532 |
| 30 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.39735052 |
| 31 | thyroid hormone generation (GO:0006590) | 3.39267704 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.38422221 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.33212253 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.32587178 |
| 35 | establishment of skin barrier (GO:0061436) | 3.31373008 |
| 36 | fat-soluble vitamin catabolic process (GO:0042363) | 3.27441288 |
| 37 | vitamin catabolic process (GO:0009111) | 3.27441288 |
| 38 | regulation of dendritic spine development (GO:0060998) | 3.27056288 |
| 39 | regulation of vesicle fusion (GO:0031338) | 3.25779031 |
| 40 | ephrin receptor signaling pathway (GO:0048013) | 3.21988750 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13080971 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13080971 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.13080971 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13080971 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.13080971 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13080971 |
| 47 | heart valve morphogenesis (GO:0003179) | 3.11235645 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.09701938 |
| 49 | neural crest cell development (GO:0014032) | 3.08911080 |
| 50 | carnitine metabolic process (GO:0009437) | 3.06916269 |
| 51 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.03345099 |
| 52 | negative regulation of cell aging (GO:0090344) | 2.99911528 |
| 53 | atrial cardiac muscle cell action potential (GO:0086014) | 2.97213636 |
| 54 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94477319 |
| 55 | cell proliferation involved in metanephros development (GO:0072203) | 2.94267256 |
| 56 | protein heterotetramerization (GO:0051290) | 2.93816786 |
| 57 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.91641420 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89347529 |
| 59 | negative regulation of catenin import into nucleus (GO:0035414) | 2.85448532 |
| 60 | regulation of water loss via skin (GO:0033561) | 2.84921633 |
| 61 | photoreceptor cell differentiation (GO:0046530) | 2.83872457 |
| 62 | eye photoreceptor cell differentiation (GO:0001754) | 2.83872457 |
| 63 | urogenital system development (GO:0001655) | 2.82666701 |
| 64 | renal system process involved in regulation of blood volume (GO:0001977) | 2.81470634 |
| 65 | mesenchymal cell development (GO:0014031) | 2.77620323 |
| 66 | sphingoid metabolic process (GO:0046519) | 2.76772242 |
| 67 | motile cilium assembly (GO:0044458) | 2.73089849 |
| 68 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.71101405 |
| 69 | positive regulation of fibroblast migration (GO:0010763) | 2.70606565 |
| 70 | keratinocyte proliferation (GO:0043616) | 2.68913921 |
| 71 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.68130196 |
| 72 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 2.67498942 |
| 73 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.66818413 |
| 74 | regulation of bile acid biosynthetic process (GO:0070857) | 2.66309949 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65634763 |
| 76 | lung secretory cell differentiation (GO:0061140) | 2.65196521 |
| 77 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.64168071 |
| 78 | regulation of cellular senescence (GO:2000772) | 2.61433386 |
| 79 | cellular potassium ion homeostasis (GO:0030007) | 2.59486004 |
| 80 | protein targeting to plasma membrane (GO:0072661) | 2.58617136 |
| 81 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.55324998 |
| 82 | fatty acid elongation (GO:0030497) | 2.53974051 |
| 83 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51741045 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51534777 |
| 85 | regulation of somitogenesis (GO:0014807) | 2.50644945 |
| 86 | sphingosine metabolic process (GO:0006670) | 2.49295606 |
| 87 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.49070374 |
| 88 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.48125303 |
| 89 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.45449983 |
| 90 | gap junction assembly (GO:0016264) | 2.45233846 |
| 91 | vocalization behavior (GO:0071625) | 2.45165402 |
| 92 | membrane assembly (GO:0071709) | 2.44101511 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.43906006 |
| 94 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.43857014 |
| 95 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.43108495 |
| 96 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.43108495 |
| 97 | retina layer formation (GO:0010842) | 2.42172715 |
| 98 | oligodendrocyte differentiation (GO:0048709) | 2.41483375 |
| 99 | protein depolymerization (GO:0051261) | 2.40863587 |
| 100 | lung epithelial cell differentiation (GO:0060487) | 2.39044395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.59643645 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.25779524 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.88330004 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.84414457 |
| 5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.83672324 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71925476 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50430315 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47379806 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46559062 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42672346 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41855550 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40008132 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30749615 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30749615 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23724449 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22441284 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14034055 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07253031 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03896916 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02742783 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00422607 |
| 22 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.95113043 |
| 23 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.84526985 |
| 24 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.82585471 |
| 25 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.82490357 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79981257 |
| 27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.79875789 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.77865110 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72131648 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.71744001 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.71198813 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68845816 |
| 33 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.61394409 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57630080 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56760170 |
| 36 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.49681413 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44738656 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44655145 |
| 39 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38104113 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35404661 |
| 41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28395477 |
| 42 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26933873 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26590135 |
| 44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25246153 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24434027 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22602286 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20633000 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20618440 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19810185 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19134132 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18555659 |
| 52 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18047481 |
| 53 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17571659 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16617817 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15537866 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14831388 |
| 57 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.13587222 |
| 58 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13189413 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13133309 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11641148 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09965568 |
| 62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07990270 |
| 63 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06903038 |
| 64 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06726245 |
| 65 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06405191 |
| 66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05954192 |
| 67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05437764 |
| 68 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.04100699 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03013105 |
| 70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02801175 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99097185 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98228336 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97597391 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97150286 |
| 75 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96964486 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95101174 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94515643 |
| 78 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93616318 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92668061 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92579309 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92579309 |
| 82 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92397033 |
| 83 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.90540294 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89992625 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89774150 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89620468 |
| 87 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.89518105 |
| 88 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89313512 |
| 89 | JUN_21703547_ChIP-Seq_K562_Human | 0.89248078 |
| 90 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89230827 |
| 91 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89212231 |
| 92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.89050876 |
| 93 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.88961481 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88933883 |
| 95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88098312 |
| 96 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.86357794 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86357001 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86106264 |
| 99 | AR_19668381_ChIP-Seq_PC3_Human | 0.86090112 |
| 100 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86030754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 9.14132482 |
| 2 | MP0005451_abnormal_body_composition | 4.74184213 |
| 3 | MP0003136_yellow_coat_color | 4.34580211 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.89050318 |
| 5 | MP0005409_darkened_coat_color | 3.16445186 |
| 6 | MP0005670_abnormal_white_adipose | 2.72973558 |
| 7 | MP0000762_abnormal_tongue_morphology | 2.64755269 |
| 8 | MP0000049_abnormal_middle_ear | 2.37145963 |
| 9 | MP0010030_abnormal_orbit_morphology | 2.36033060 |
| 10 | MP0004381_abnormal_hair_follicle | 2.28778061 |
| 11 | MP0004270_analgesia | 2.05374989 |
| 12 | MP0001270_distended_abdomen | 2.02859315 |
| 13 | MP0008789_abnormal_olfactory_epithelium | 1.94739434 |
| 14 | MP0000015_abnormal_ear_pigmentation | 1.94669183 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 1.94524207 |
| 16 | MP0003880_abnormal_central_pattern | 1.73877313 |
| 17 | MP0005394_taste/olfaction_phenotype | 1.73002394 |
| 18 | MP0005499_abnormal_olfactory_system | 1.73002394 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 1.70128939 |
| 20 | MP0003011_delayed_dark_adaptation | 1.66248441 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.62249044 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.61298513 |
| 23 | MP0005171_absent_coat_pigmentation | 1.58471995 |
| 24 | MP0002177_abnormal_outer_ear | 1.57222622 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.49956683 |
| 26 | MP0008569_lethality_at_weaning | 1.44366627 |
| 27 | MP0009046_muscle_twitch | 1.44198322 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.37873087 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.31472640 |
| 30 | MP0002822_catalepsy | 1.31345489 |
| 31 | MP0000647_abnormal_sebaceous_gland | 1.30373891 |
| 32 | MP0003195_calcinosis | 1.30233058 |
| 33 | MP0009745_abnormal_behavioral_response | 1.29568148 |
| 34 | MP0002938_white_spotting | 1.29363971 |
| 35 | MP0001188_hyperpigmentation | 1.25194714 |
| 36 | MP0000427_abnormal_hair_cycle | 1.24133631 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.22254125 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.21552760 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.21087884 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.20734705 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.11395737 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.10463284 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.07431103 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.07340102 |
| 45 | MP0002064_seizures | 1.06775109 |
| 46 | MP0004858_abnormal_nervous_system | 1.05445971 |
| 47 | MP0000751_myopathy | 1.04671013 |
| 48 | MP0001486_abnormal_startle_reflex | 1.04032828 |
| 49 | MP0003632_abnormal_nervous_system | 1.03303704 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.01785250 |
| 51 | MP0001664_abnormal_digestion | 1.00211513 |
| 52 | MP0005386_behavior/neurological_phenoty | 0.99984913 |
| 53 | MP0004924_abnormal_behavior | 0.99984913 |
| 54 | MP0002272_abnormal_nervous_system | 0.98368750 |
| 55 | MP0003690_abnormal_glial_cell | 0.97751235 |
| 56 | MP0005508_abnormal_skeleton_morphology | 0.97134664 |
| 57 | MP0006292_abnormal_olfactory_placode | 0.95671169 |
| 58 | MP0002249_abnormal_larynx_morphology | 0.94552512 |
| 59 | MP0002972_abnormal_cardiac_muscle | 0.94516602 |
| 60 | MP0005187_abnormal_penis_morphology | 0.93560783 |
| 61 | MP0003718_maternal_effect | 0.91288005 |
| 62 | MP0000428_abnormal_craniofacial_morphol | 0.87310957 |
| 63 | MP0005620_abnormal_muscle_contractility | 0.85778139 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.83206589 |
| 65 | MP0001485_abnormal_pinna_reflex | 0.83133253 |
| 66 | MP0001502_abnormal_circadian_rhythm | 0.83038341 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.82804004 |
| 68 | MP0002736_abnormal_nociception_after | 0.82705860 |
| 69 | MP0001851_eye_inflammation | 0.82546311 |
| 70 | MP0010678_abnormal_skin_adnexa | 0.81200282 |
| 71 | MP0002233_abnormal_nose_morphology | 0.79370216 |
| 72 | MP0002572_abnormal_emotion/affect_behav | 0.78493981 |
| 73 | MP0002896_abnormal_bone_mineralization | 0.77248784 |
| 74 | MP0003137_abnormal_impulse_conducting | 0.77001136 |
| 75 | MP0001340_abnormal_eyelid_morphology | 0.75444118 |
| 76 | MP0001529_abnormal_vocalization | 0.73583196 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.72244490 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 0.72163378 |
| 79 | MP0004142_abnormal_muscle_tone | 0.71762766 |
| 80 | MP0004742_abnormal_vestibular_system | 0.70422053 |
| 81 | MP0000163_abnormal_cartilage_morphology | 0.70389298 |
| 82 | MP0003755_abnormal_palate_morphology | 0.69957945 |
| 83 | MP0000026_abnormal_inner_ear | 0.68123537 |
| 84 | MP0000747_muscle_weakness | 0.68120963 |
| 85 | MP0002063_abnormal_learning/memory/cond | 0.67642868 |
| 86 | MP0005381_digestive/alimentary_phenotyp | 0.66705768 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.66038678 |
| 88 | MP0000778_abnormal_nervous_system | 0.65120451 |
| 89 | MP0000383_abnormal_hair_follicle | 0.61660569 |
| 90 | MP0010771_integument_phenotype | 0.61619813 |
| 91 | MP0001324_abnormal_eye_pigmentation | 0.61561122 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.61502033 |
| 93 | MP0002282_abnormal_trachea_morphology | 0.61178051 |
| 94 | MP0001663_abnormal_digestive_system | 0.60747807 |
| 95 | MP0004036_abnormal_muscle_relaxation | 0.57607421 |
| 96 | MP0008057_abnormal_DNA_replication | 0.57463599 |
| 97 | MP0001177_atelectasis | 0.56628140 |
| 98 | MP0005165_increased_susceptibility_to | 0.56401785 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.55686067 |
| 100 | MP0001984_abnormal_olfaction | 0.55013466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mixed hearing impairment (HP:0000410) | 7.08976615 |
| 2 | Erythema (HP:0010783) | 6.69484981 |
| 3 | Fragile nails (HP:0001808) | 5.82517341 |
| 4 | Distal lower limb muscle weakness (HP:0009053) | 5.51492119 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.72846664 |
| 6 | Alopecia of scalp (HP:0002293) | 4.39664163 |
| 7 | Follicular hyperkeratosis (HP:0007502) | 4.23933689 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 3.91532491 |
| 9 | Hyperventilation (HP:0002883) | 3.81650796 |
| 10 | Focal motor seizures (HP:0011153) | 3.63693795 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 3.62213068 |
| 12 | Milia (HP:0001056) | 3.42610300 |
| 13 | Aplasia cutis congenita (HP:0001057) | 3.42394509 |
| 14 | Steppage gait (HP:0003376) | 3.42255484 |
| 15 | Septate vagina (HP:0001153) | 3.39915626 |
| 16 | Patchy hypopigmentation of hair (HP:0011365) | 3.24235942 |
| 17 | Onycholysis (HP:0001806) | 3.23680531 |
| 18 | Osteomalacia (HP:0002749) | 3.16850558 |
| 19 | Concave nail (HP:0001598) | 3.16771088 |
| 20 | Abnormal blistering of the skin (HP:0008066) | 3.15597297 |
| 21 | Neonatal short-limb short stature (HP:0008921) | 3.12185947 |
| 22 | Atrophic scars (HP:0001075) | 3.09724897 |
| 23 | White forelock (HP:0002211) | 3.08447242 |
| 24 | Aplasia involving bones of the extremities (HP:0009825) | 3.05605231 |
| 25 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.05605231 |
| 26 | Aplasia of the phalanges of the hand (HP:0009802) | 3.05605231 |
| 27 | Plantar hyperkeratosis (HP:0007556) | 2.89077861 |
| 28 | Febrile seizures (HP:0002373) | 2.87871774 |
| 29 | Sensory axonal neuropathy (HP:0003390) | 2.86136438 |
| 30 | Delayed CNS myelination (HP:0002188) | 2.82981428 |
| 31 | Hypophosphatemic rickets (HP:0004912) | 2.77831278 |
| 32 | Hydroureter (HP:0000072) | 2.71210606 |
| 33 | Sparse eyelashes (HP:0000653) | 2.69611635 |
| 34 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.67368425 |
| 35 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.64862994 |
| 36 | Neurofibrillary tangles (HP:0002185) | 2.63587782 |
| 37 | Epileptic encephalopathy (HP:0200134) | 2.63221339 |
| 38 | Xerostomia (HP:0000217) | 2.56927421 |
| 39 | Dialeptic seizures (HP:0011146) | 2.55939195 |
| 40 | Focal seizures (HP:0007359) | 2.47424220 |
| 41 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.42408432 |
| 42 | Woolly hair (HP:0002224) | 2.41197480 |
| 43 | Pili torti (HP:0003777) | 2.41162657 |
| 44 | Hypoplastic left heart (HP:0004383) | 2.35054919 |
| 45 | Methylmalonic acidemia (HP:0002912) | 2.34852829 |
| 46 | Blepharitis (HP:0000498) | 2.31228831 |
| 47 | Blue irides (HP:0000635) | 2.29941138 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.29687976 |
| 49 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.28305592 |
| 50 | Hypoplasia of the fovea (HP:0007750) | 2.28305592 |
| 51 | Stomatitis (HP:0010280) | 2.27443675 |
| 52 | Keratitis (HP:0000491) | 2.23034976 |
| 53 | Abnormal sex determination (HP:0012244) | 2.21476044 |
| 54 | Sex reversal (HP:0012245) | 2.21476044 |
| 55 | Hypoventilation (HP:0002791) | 2.19604498 |
| 56 | Down-sloping shoulders (HP:0200021) | 2.19409915 |
| 57 | Pustule (HP:0200039) | 2.19139561 |
| 58 | Cerebral inclusion bodies (HP:0100314) | 2.16845999 |
| 59 | Ulnar claw (HP:0001178) | 2.14782715 |
| 60 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14057689 |
| 61 | Rectovaginal fistula (HP:0000143) | 2.12591836 |
| 62 | Rectal fistula (HP:0100590) | 2.12591836 |
| 63 | Hemiparesis (HP:0001269) | 2.12552731 |
| 64 | Status epilepticus (HP:0002133) | 2.11631991 |
| 65 | Abnormal hair laboratory examination (HP:0003328) | 2.11582629 |
| 66 | Orchitis (HP:0100796) | 2.04805101 |
| 67 | Hyperphosphatemia (HP:0002905) | 2.02713944 |
| 68 | Natal tooth (HP:0000695) | 1.99445294 |
| 69 | Neoplasm of the heart (HP:0100544) | 1.99062464 |
| 70 | Abnormality of the calf musculature (HP:0001430) | 1.97021457 |
| 71 | Hypodontia (HP:0000668) | 1.96836206 |
| 72 | Areflexia of lower limbs (HP:0002522) | 1.95872032 |
| 73 | Flat capital femoral epiphysis (HP:0003370) | 1.94610476 |
| 74 | Urethral obstruction (HP:0000796) | 1.92349901 |
| 75 | Methylmalonic aciduria (HP:0012120) | 1.90195750 |
| 76 | Amelogenesis imperfecta (HP:0000705) | 1.87996817 |
| 77 | Increased hepatocellular lipid droplets (HP:0006565) | 1.87637053 |
| 78 | Tibial bowing (HP:0002982) | 1.87626067 |
| 79 | Complete atrioventricular canal defect (HP:0001674) | 1.87263303 |
| 80 | Thick nail (HP:0001805) | 1.87208664 |
| 81 | Absence seizures (HP:0002121) | 1.86535934 |
| 82 | Optic neuritis (HP:0100653) | 1.84385622 |
| 83 | Retrobulbar optic neuritis (HP:0100654) | 1.84385622 |
| 84 | Onion bulb formation (HP:0003383) | 1.82801310 |
| 85 | Abnormality of the dental root (HP:0006486) | 1.82264386 |
| 86 | Taurodontia (HP:0000679) | 1.82264386 |
| 87 | Abnormality of permanent molar morphology (HP:0011071) | 1.82264386 |
| 88 | Shoulder girdle muscle weakness (HP:0003547) | 1.81926348 |
| 89 | Atrioventricular canal defect (HP:0006695) | 1.81424567 |
| 90 | Ectropion (HP:0000656) | 1.81120901 |
| 91 | Hypoplastic heart (HP:0001961) | 1.80657584 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 1.80189747 |
| 93 | Abnormality of the fovea (HP:0000493) | 1.76116093 |
| 94 | Increased connective tissue (HP:0009025) | 1.75900718 |
| 95 | Intestinal fistula (HP:0100819) | 1.75771730 |
| 96 | Cerebral hemorrhage (HP:0001342) | 1.75018575 |
| 97 | Atonic seizures (HP:0010819) | 1.74841065 |
| 98 | Generalized tonic-clonic seizures (HP:0002069) | 1.74426732 |
| 99 | Abnormality of the foot musculature (HP:0001436) | 1.73915179 |
| 100 | Vaginal fistula (HP:0004320) | 1.72952971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 7.19265882 |
| 2 | MKNK2 | 7.02930907 |
| 3 | PBK | 6.78791894 |
| 4 | MKNK1 | 4.97152566 |
| 5 | CSNK1G2 | 2.62736343 |
| 6 | CASK | 1.49294314 |
| 7 | PKN2 | 1.48229889 |
| 8 | EPHA4 | 1.38211153 |
| 9 | STK16 | 1.34049674 |
| 10 | EPHB1 | 1.32567077 |
| 11 | PRKD1 | 1.31596057 |
| 12 | MAP2K7 | 1.25931744 |
| 13 | CDK12 | 1.24633846 |
| 14 | MAPKAPK3 | 1.22382570 |
| 15 | SIK3 | 1.22257628 |
| 16 | CAMKK1 | 1.19224704 |
| 17 | SIK2 | 1.14038550 |
| 18 | PIK3CA | 1.06189273 |
| 19 | PRKCG | 1.04821088 |
| 20 | RIPK4 | 0.98362102 |
| 21 | RIPK1 | 0.96592123 |
| 22 | PAK6 | 0.94160870 |
| 23 | PTK6 | 0.90152646 |
| 24 | STK39 | 0.90091059 |
| 25 | PRKD3 | 0.86435692 |
| 26 | UHMK1 | 0.84592978 |
| 27 | DMPK | 0.84459150 |
| 28 | MARK2 | 0.84239802 |
| 29 | MAP2K4 | 0.83484893 |
| 30 | INSRR | 0.82924465 |
| 31 | CAMK2D | 0.81935774 |
| 32 | PAK3 | 0.79596591 |
| 33 | PLK2 | 0.78491652 |
| 34 | DYRK1A | 0.77082791 |
| 35 | SIK1 | 0.74640804 |
| 36 | FES | 0.74087881 |
| 37 | GRK7 | 0.71082625 |
| 38 | BTK | 0.70632250 |
| 39 | ROCK1 | 0.68864988 |
| 40 | RPS6KB2 | 0.68050377 |
| 41 | DYRK3 | 0.65915230 |
| 42 | CAMK2A | 0.63791743 |
| 43 | FER | 0.59573642 |
| 44 | MAPK12 | 0.57256198 |
| 45 | PRKCE | 0.57088040 |
| 46 | EPHB2 | 0.56758916 |
| 47 | PHKG1 | 0.55358361 |
| 48 | PHKG2 | 0.55358361 |
| 49 | MARK3 | 0.55216055 |
| 50 | MAPKAPK5 | 0.54821082 |
| 51 | BCR | 0.52549900 |
| 52 | MAP2K1 | 0.52428941 |
| 53 | PTK2B | 0.52329247 |
| 54 | EIF2AK2 | 0.52291836 |
| 55 | MAP3K4 | 0.51928739 |
| 56 | HCK | 0.50447400 |
| 57 | NTRK1 | 0.48368112 |
| 58 | PINK1 | 0.48283962 |
| 59 | TLK1 | 0.48202963 |
| 60 | CAMK2B | 0.47003881 |
| 61 | OXSR1 | 0.46962651 |
| 62 | MINK1 | 0.46786204 |
| 63 | OBSCN | 0.46539100 |
| 64 | PRKG1 | 0.45906859 |
| 65 | PRKACA | 0.45741178 |
| 66 | PAK2 | 0.45655437 |
| 67 | LIMK1 | 0.43575963 |
| 68 | CDK14 | 0.43384233 |
| 69 | ROCK2 | 0.43106590 |
| 70 | DYRK1B | 0.41308563 |
| 71 | CDK5 | 0.41250837 |
| 72 | WNK1 | 0.40697278 |
| 73 | ERN1 | 0.40538263 |
| 74 | TXK | 0.39338787 |
| 75 | ADRBK2 | 0.37958583 |
| 76 | PRKACB | 0.37090654 |
| 77 | GSK3A | 0.36926006 |
| 78 | MARK1 | 0.36108707 |
| 79 | PRKCB | 0.35769391 |
| 80 | STK24 | 0.34991651 |
| 81 | NTRK2 | 0.33868403 |
| 82 | MAP3K14 | 0.33866952 |
| 83 | MAPK4 | 0.33651184 |
| 84 | PRKCA | 0.33549697 |
| 85 | RAF1 | 0.31157307 |
| 86 | CDK15 | 0.30793489 |
| 87 | MAP3K6 | 0.30756802 |
| 88 | PRKD2 | 0.30344096 |
| 89 | MAPK13 | 0.29669356 |
| 90 | CSNK1A1 | 0.28050050 |
| 91 | NTRK3 | 0.27545239 |
| 92 | FYN | 0.27262341 |
| 93 | PKN1 | 0.26961462 |
| 94 | CDK18 | 0.26852659 |
| 95 | MAPK7 | 0.25918687 |
| 96 | ADRBK1 | 0.25874793 |
| 97 | MAPK10 | 0.25431632 |
| 98 | FGR | 0.25301213 |
| 99 | EGFR | 0.25228757 |
| 100 | MAPKAPK2 | 0.24390697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.29101943 |
| 2 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.13504018 |
| 3 | Taste transduction_Homo sapiens_hsa04742 | 1.88258533 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.83440016 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 1.74567873 |
| 6 | Salivary secretion_Homo sapiens_hsa04970 | 1.73629641 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.71310752 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.70723209 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.68051802 |
| 10 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.64261596 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63154043 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.59312354 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57325862 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.56450466 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53660968 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52128490 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48308741 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.45019006 |
| 19 | Axon guidance_Homo sapiens_hsa04360 | 1.41935694 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.36984180 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.36255271 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28405395 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27191083 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.23695457 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23445794 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19846251 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18122978 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15833495 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15442384 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15192937 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14682339 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12872089 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.11166057 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06910043 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.05036108 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.00372068 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.00270912 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97743753 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96130223 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92195509 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90620217 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89950881 |
| 43 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89289973 |
| 44 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87724167 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87284499 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86260087 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84418586 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83523160 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82717849 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 0.80930242 |
| 51 | Melanoma_Homo sapiens_hsa05218 | 0.80124246 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79595660 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79441935 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79397604 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78722120 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78382077 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77319120 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76961980 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76391644 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.75255216 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75099160 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74620026 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73819187 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73800796 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.73219283 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72940572 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72404688 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72244412 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72067546 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71125035 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70169204 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.68828225 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68192220 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68140250 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67717601 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67539968 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67346877 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66922314 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66776447 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64690280 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64390807 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.63847757 |
| 83 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63236361 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62735647 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62100677 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61277219 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58032963 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57867643 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.54141276 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50912515 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50423857 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48550636 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.47992099 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47054301 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46747383 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44855130 |
| 97 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44060298 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.43876528 |
| 99 | * Tuberculosis_Homo sapiens_hsa05152 | 0.43191774 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43133072 |

